ID   PAK6_HUMAN              Reviewed;         681 AA.
AC   Q9NQU5;
DT   19-SEP-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   05-OCT-2010, entry version 98.
DE   RecName: Full=Serine/threonine-protein kinase PAK 6;
DE            EC=2.7.11.1;
DE   AltName: Full=PAK-5;
DE   AltName: Full=p21-activated kinase 6;
DE            Short=PAK-6;
GN   Name=PAK6; Synonyms=PAK5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=21226785; PubMed=11278661; DOI=10.1074/jbc.M010311200;
RA   Yang F., Li X., Sharma M., Zarnegar M., Lim B., Sun Z.;
RT   "Androgen receptor specifically interacts with a novel p21-activated
RT   kinase, PAK6.";
RL   J. Biol. Chem. 276:15345-15353(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Wagner T., Puls A., Frischauf A.M., Hall A.;
RT   "Pak5, a new member of the p21-activated kinase family, affects Cdc42
RT   signalling to the actin cytoskeleton.";
RL   Submitted (FEB-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-560, AND MASS
RP   SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-560, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 383-681, AND PHOSPHORYLATION
RP   AT SER-560.
RA   Filippakopoulos P., Berridge G., Bray J., Burgess N., Colebrook S.,
RA   Das S., Eswaran J., Gileadi O., Papagrigoriou E., Savitsky P.,
RA   Smee C., Turnbull A., Sundstrom M., Arrowsmith C., Weigelt J.,
RA   Edwards A., Von Delft F., Knapp S.;
RT   "Crystal structure of the human p21-activated kinase 6.";
RL   Submitted (FEB-2006) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 11-45 IN COMPLEX WITH CDC42.
RG   Structural genomics consortium (SGC);
RT   "The crystal structure of human CDC42 in complex with the CRIB domain
RT   of human p21-activated kinase 6 (PAK6).";
RL   Submitted (JAN-2007) to the PDB data bank.
RN   [8]
RP   VARIANT [LARGE SCALE ANALYSIS] HIS-3.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [9]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-76; LYS-184; GLU-205; THR-208;
RP   MET-210; ARG-215; LEU-337; VAL-376 AND ARG-514.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: The activated kinase acts on a variety of targets (By
CC       similarity).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Interacts tightly with GTP-bound but not GDP-bound
CC       CDC42/p21 and RAC1 (By similarity). Interacts with the androgen
CC       receptor.
CC   -!- INTERACTION:
CC       P27348:YWHAQ; NbExp=1; IntAct=EBI-1053685, EBI-359854;
CC   -!- PTM: Autophosphorylated when activated by CDC42/p21 (By
CC       similarity).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily.
CC   -!- SIMILARITY: Contains 1 CRIB domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF276893; AAF82800.1; -; mRNA.
DR   EMBL; AJ236915; CAC18720.1; -; mRNA.
DR   EMBL; BC035596; AAH35596.1; -; mRNA.
DR   IPI; IPI00024584; -.
DR   RefSeq; NP_001122100.1; -.
DR   RefSeq; NP_001122101.1; -.
DR   RefSeq; NP_064553.1; -.
DR   UniGene; Hs.513645; -.
DR   PDB; 2C30; X-ray; 1.60 A; A=383-681.
DR   PDB; 2ODB; X-ray; 2.40 A; B=11-45.
DR   PDBsum; 2C30; -.
DR   PDBsum; 2ODB; -.
DR   ProteinModelPortal; Q9NQU5; -.
DR   SMR; Q9NQU5; 4-66.
DR   IntAct; Q9NQU5; 1.
DR   STRING; Q9NQU5; -.
DR   PhosphoSite; Q9NQU5; -.
DR   PRIDE; Q9NQU5; -.
DR   Ensembl; ENST00000260404; ENSP00000260404; ENSG00000137843.
DR   Ensembl; ENST00000441369; ENSP00000406873; ENSG00000137843.
DR   Ensembl; ENST00000453867; ENSP00000401153; ENSG00000137843.
DR   GeneID; 56924; -.
DR   KEGG; hsa:56924; -.
DR   UCSC; uc001zlb.2; human.
DR   CTD; 56924; -.
DR   GeneCards; GC15P040509; -.
DR   HGNC; HGNC:16061; PAK6.
DR   HPA; HPA031124; -.
DR   MIM; 608110; gene.
DR   PharmGKB; PA32921; -.
DR   eggNOG; prNOG11420; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG108518; -.
DR   InParanoid; Q9NQU5; -.
DR   OMA; SPSPKTQ; -.
DR   OrthoDB; EOG9HX7M4; -.
DR   PhylomeDB; Q9NQU5; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Reactome; REACT_18266; Axon guidance.
DR   NextBio; 62436; -.
DR   ArrayExpress; Q9NQU5; -.
DR   Bgee; Q9NQU5; -.
DR   CleanEx; HS_PAK6; -.
DR   Genevestigator; Q9NQU5; -.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000095; PAK_box_Rho-bd.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR015750; Ser/Thr_kinase_Pak-rel.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   PANTHER; PTHR22986:SF84; Pak_like; 1.
DR   Pfam; PF00786; PBD; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00285; PBD; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50108; CRIB; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; FALSE_NEG.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    681       Serine/threonine-protein kinase PAK 6.
FT                                /FTId=PRO_0000086476.
FT   DOMAIN       12     25       CRIB.
FT   DOMAIN      407    658       Protein kinase.
FT   NP_BIND     413    421       ATP (By similarity).
FT   REGION       26    406       Linker.
FT   ACT_SITE    526    526       Proton acceptor (By similarity).
FT   BINDING     436    436       ATP (By similarity).
FT   MOD_RES     560    560       Phosphoserine.
FT   VARIANT       3      3       R -> H (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                /FTId=VAR_035631.
FT   VARIANT      76     76       M -> V (in dbSNP:rs2412504).
FT                                /FTId=VAR_019993.
FT   VARIANT     103    103       R -> C (in dbSNP:rs36081263).
FT                                /FTId=VAR_051655.
FT   VARIANT     151    151       T -> I (in dbSNP:rs35593179).
FT                                /FTId=VAR_051656.
FT   VARIANT     184    184       E -> K (in dbSNP:rs56349744).
FT                                /FTId=VAR_040972.
FT   VARIANT     205    205       G -> E (in dbSNP:rs55920845).
FT                                /FTId=VAR_040973.
FT   VARIANT     208    208       P -> T (in dbSNP:rs35501648).
FT                                /FTId=VAR_040974.
FT   VARIANT     210    210       T -> M (in dbSNP:rs34869667).
FT                                /FTId=VAR_040975.
FT   VARIANT     215    215       H -> R (in dbSNP:rs3743135).
FT                                /FTId=VAR_019994.
FT   VARIANT     337    337       P -> L (in dbSNP:rs3743137).
FT                                /FTId=VAR_019995.
FT   VARIANT     376    376       A -> V (in dbSNP:rs55806501).
FT                                /FTId=VAR_040976.
FT   VARIANT     475    475       E -> K (in dbSNP:rs34445577).
FT                                /FTId=VAR_051657.
FT   VARIANT     514    514       L -> R (in a lung small cell carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040977.
FT   STRAND       16     27
FT   TURN         28     31
FT   STRAND       32     35
FT   HELIX        38     44
FT   HELIX       387    395
FT   HELIX       403    406
FT   STRAND      407    416
FT   STRAND      419    426
FT   TURN        427    429
FT   STRAND      432    439
FT   TURN        440    442
FT   HELIX       446    456
FT   STRAND      467    473
FT   STRAND      476    481
FT   HELIX       489    493
FT   HELIX       500    519
FT   HELIX       529    531
FT   STRAND      532    534
FT   STRAND      540    542
FT   STRAND      553    555
FT   HELIX       565    567
FT   HELIX       570    573
FT   HELIX       581    596
FT   TURN        600    603
FT   HELIX       606    615
FT   HELIX       624    626
FT   HELIX       629    638
FT   TURN        643    645
FT   HELIX       649    653
FT   HELIX       656    660
FT   HELIX       664    667
FT   HELIX       668    673
SQ   SEQUENCE   681 AA;  74869 MW;  F20A4FA257649BB9 CRC64;
     MFRKKKKKRP EISAPQNFQH RVHTSFDPKE GKFVGLPPQW QNILDTLRRP KPVVDPSRIT
     RVQLQPMKTV VRGSAMPVDG YISGLLNDIQ KLSVISSNTL RGRSPTSRRR AQSLGLLGDE
     HWATDPDMYL QSPQSERTDP HGLYLSCNGG TPAGHKQMPW PEPQSPRVLP NGLAAKAQSL
     GPAEFQGASQ RCLQLGACLQ SSPPGASPPT GTNRHGMKAA KHGSEEARPQ SCLVGSATGR
     PGGEGSPSPK TRESSLKRRL FRSMFLSTAA TAPPSSSKPG PPPQSKPNSS FRPPQKDNPP
     SLVAKAQSLP SDQPVGTFSP LTTSDTSSPQ KSLRTAPATG QLPGRSSPAG SPRTWHAQIS
     TSNLYLPQDP TVAKGALAGE DTGVVTHEQF KAALRMVVDQ GDPRLLLDSY VKIGEGSTGI
     VCLAREKHSG RQVAVKMMDL RKQQRRELLF NEVVIMRDYQ HFNVVEMYKS YLVGEELWVL
     MEFLQGGALT DIVSQVRLNE EQIATVCEAV LQALAYLHAQ GVIHRDIKSD SILLTLDGRV
     KLSDFGFCAQ ISKDVPKRKS LVGTPYWMAP EVISRSLYAT EVDIWSLGIM VIEMVDGEPP
     YFSDSPVQAM KRLRDSPPPK LKNSHKVSPV LRDFLERMLV RDPQERATAQ ELLDHPFLLQ
     TGLPECLVPL IQLYRKQTST C
//
